Skip to Content

Evolutionary Genomics Inc FNAM

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Evolutionary Genomics Inc is a genomics research and development company focused on the identification and validation of genes that impact valuable traits in crops for the agriculture industry. The company also research on drought tolerance in multiple crops. The company's core technology is Adapted Traits Platform which is used to perform molecular evolution analysis to identify positively selected genes that may have an impact on traits of interest.

Contact
1026 Anaconda Drive
Castle Rock, CO, 80108
T +1 720 900-8666
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Dec 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type Slow Growth
Employees 2